A quantitative radioassay was used to study the 
A quantitative radioassay was used to study the adherence of group A Streptococcus to Madin-Darby canine kidney cells infected with influenza A virus (strains FM1, Jap 305, and NWS) and reacted with fibrinogen. Treatment of virusinfected cell cultures with human fibrinogen significantly enhanced streptococcal adherence (P < 0.0005) compared with adherence to untreated, virus-infected cells and uninfected control cells. Enhanced adherence was not seen with NWS virus-infected cell cultures or with virus-infected cells treated with human fibronectin, canine fibrinogen, or porcine fibrinogen. Human fibrinogen was shown to bind directly to surface membranes of virus-infected cells. Virusinfected cell cultures were incubated in the presence of tunicamycin, an antibiotic that inhibits glycosylation of virus-specific surface membrane glycoproteins. We found that with increasing antibiotic concentration there was a progressive decrease in fibrinogen-mediated streptococcal adherence. Adherence of 3H-labeled streptococci to fibrinogen-treated, virus-infected cell cultures showed saturation kinetics and could be blocked with monospecific antibodies against fibrinogen. These results suggest that human fibrinogen binds to a glycoprotein moiety on the surface of influenza A virus-infected cells, and that once bound the fibrinogen molecule acts as an "acquired" receptor for the attachment of group A Streptococcus. We postulate that this mechanism, it if occurs in vivo, might help explain the observed association between influenza A virus infection and subsequent bacterial superinfection with group A Streptococcus.
Secondary bacterial pneumonia is a serious complication of influenza virus infection in humans and is responsible for the excess morbidity and mortality seen during influenza epidemics. The bacteria closely associated with complications in influenza include the following: Staphylococcus aureus, group A Streptococcus, Streptococcus pneumoniae, Hemophilus influenzae, Klebsiella pneumoniae, and Neisseria meningitidis (15) . In an ongoing effort to explain this close association, we have used an in vitro cell culture model system to study the adherence of bacterial respiratory pathogens to influenza A virus-infected cells (5, 6, 20, 21) . Results show that adherence of S. aureus clinical isolates is significantly higher with mammalian cells infected with human strains of influenza A virus compared with adherence to uninfected control cells (5) . Recently, we reported that the addition of human fibrinogen further enhanced staphylococcal adherence to virus-infected cells (6) . These results suggest a mechanism by which host proteins play a role in promoting the synergistic interaction of influenza A virus and staphylococci. The present study was done to test the possibility that fibrinogen-mediated adherence is a general mechanism which works with respiratory pathogens other than S. aureus. We also report the effect of various factors on the adherence phenomenon.
MATERIALS AND METHODS
Ceil cultures. Madin-Darby canine kidney cells (MDCK) were routinely maintained in Eagle basal medium (Auto Pow BME; Flow Laboratories, Rockville, Md.) with 10o fetal calf serum, 0.03% L-glutamine, penicillin (100 U/ml), and streptomycin (100 ,ug/ ml). Before each experiment, cells were grown in sixwell LinBro plates (LinBro Scientific Co., Inc., Hamden, Conn.) in BME and incubated at 37°C in a 5% CO2 atmosphere until 90%o confluent.
Viruses. Three strains of influenza A virus were used to infect cell monolayers, as previously described (5 A909) (21) were used. Cultures were stored and grown as previously described (20) .
Radioassay. Details of the radioassay test system have previously been reported (5) . Briefly, streptococci were labeled by culturing in Todd-Hewitt broth (BBL Microbiology Systems, Cockeysville, Md.) containing 1 ,uCi of [methyl-3H]thymidine (specific activity, 20 Ci/mmol; ICN Chemical and Radioisotope Division, Irvine, Calif.) per ml of medium at 37°C for 18 h with constant agitation. The 3H-labeled streptococci were harvested by centrifugation and repeatedly washed with PBS until no more radioactivity could be detected in the washes. Labeled streptococci were aliquoted and stored frozen at -20°C in PBS. Before being added to the monolayers, the labeled bacteria were washed once with PBS. This step eliminated any unbound isotope which could conceivably be taken up by the viable MDCK cells, thus giving erroneous test results.
Influenza A virus-infected and control monolayers were washed with PBS, layered with 0.5 ml of PBS diluent, 1% human fibrinogen (fraction 1; Sigma Chemical Co., St. Louis, Mo.), 1% porcine fibrinogen (fraction 1; Sigma), 1% canine fibrinogen (type V; Sigma), 0.1% human fibronectin (Sigma), or 0.15% sodium citrate (Fisher Scientific Co., Fairlawn, N.J.) and incubated at ambient temperature for 30 min with intermittent agitation. After incubation, the monolayers were washed twice with PBS and layered with 1 ml of PBS followed by the addition of 25 ,ul of 3H-labeled streptococci which contained approximately 0.25 mg (dry weight) of bacteria (2 x 108 to 3 x 108 colonyforming units). After incubation at ambient temperature for 1 h, the monolayers were washed free of unbound labeled bacteria by continually adding PBS to the plates while simultaneously aspirating the fluid. The washing procedure was continued until the monolayer was shown to be free of unbound bacteria by microscopic examination. To determine the amount of bound 3H-labeled bacteria, the washed monolayers were removed by digestion with 0.5 ml of 0.25% trypsin in 0.02% EDTA at 37°C for 15 min. The digests were transferred to scintillation vials. The wells were rinsed with 0.5 ml of water which was also added to each vial. A 10-ml amount of ScintiVerse scintillation cocktail (Fisher) was added to each vial, and radioactivity was measured in a Beckman Mark III liquid scintillation spectrometer. Counts per minute were converted to disintegrations per minute to increase the accuracy of the procedure. All experiments were run at least in triplicate. The mean and standard error of the mean were determined. Significance of differences between means was analyzed by using Student's t test. Ratios are used to express the fold difference of mean disintegrations per minute with virus-infected cells/ mean disintegrations per minute of uninfected cells.
Blocking of enhanced adherence. In an effort to determine the specificity of fibrinogen-enhanced bacterial adherence to virus-infected cells, the following experiment was done. 3H-labeled streptococci were added to washed virus-infected and control cell cultures which had been incubated at ambient temperature for 30 min with the following: PBS, a 1:2 dilution of goat antihuman fibrinogen (Cappel Laboratories, Inc., Cochranville, Pa.) and then PBS, 1% human fibrinogen and then PBS, and 1% human fibrinogen and then a 1:2 dilution of the anti-human fibrinogen. Monolayers were washed with PBS after each incubation and processed for the determination of bound 3H-labeled bacteria as described above.
The effect of tunicamycin on fibrinogen-mediated binding was also determined by inoculating MDCK cell monolayers with PBS diluent or virus as described above and adding various concentrations of tunicamycin in BME to the monolayers. After incubating at 34°C for 24 h, the monolayers were used in the radioassay.
Direct binding of fibrinogen. To determine whether fibrinogen was actually binding to cell monolayers, two approaches were used. In the first, virus-infected and control cell monolayers were treated with 0.5 ml of PBS diluent or human fibrinogen (0.5, 5, and 10 mg of fibrinogen per 0.5 ml) at ambient temperature for 30 min. After washing with PBS, a 0.2-ml volume of a 1:5 dilution of fluorescein-conjugated immunoglobulin G fraction of goat antihuman fibrinogen (fluorescein/ protein ratio = 3.59 mg/g; Cappel) was added to each well for 30 min at ambient temperature. The monolayers were washed with PBS and examined microscopically for apple-green fluorescence (AO Spencer fluorolume illuminator, model 645) with the 50 x oil objective.
In the second approach, human fibrinogen was labeled with 125I by the chloramine T method of McConahey and Dixon (16) ratories, Grand Island, N.Y.) were added to each well and incubated for 30 min at ambient temperature. After washing with PBS, the monolayers were digested as described above and measured for radioactivity in a gamma counter (Beckman Instruments Co., Fullerton, Calif.). The 125I-labeled fibrinogen solution contained 200 ,ug of fibrinogen per 100 pul with a specific activity of -1 x 103 to 2 x 103 cpm/lpg.
A parallel experiment was run to determine whether the 125I-labeled fibrinogen was localized on the cell surface or intracellularly. After monolayers were reacted with 125I-labeled fibrinogen, they were washed and treated with trypsin at 37°C for 15 min, a procedure shown by Colvin et al. (4) to release previously bound 125I-labeled fibrinogen from the cell surface.
The contents of each well were transferred to a test tube; 0.5 ml of water, used to wash each well, was also transferred to the tube. After centrifugation, the supernatant fluid was removed, and the cell pellet was washed repeatedly with PBS and then suspended in 1 ml of PBS. The supernatant fluid and cell suspension were measured for radioactivity in a gamma counter.
Ouchterlony gel double diffusion. Immunodiffusion tests were done by the method of Piazzi (19) with 0.2% human fibrinogen in PBS and undiluted goat antihuman fibrinogen (Cappel). The agarose gels were stained with 0.1% bromphenol blue in 90% ethanol.
RESULTS
In our initial experiment four strains of streptococci were tested for their ability to adhere to uninfected and influenza A/FM/1/47 virus-infected MDCK cell monolayers, some of which had been treated with human fibrinogen (Table 1) . Group B Streptococcus type Ic was included because it is known to be adherence positive with influenza A virus-infected MDCK cells and weakly adherent with control, uninfected cells (18, 21) . Fibrinogen treatment of the cell cultures had very little effect on the adherence of this organism. Two of the three strains of group A Streptococcus tested, P2006 and E8, were adherence positive with both uninfected and virus-infected cell cultures. The most interesting results were obtained with strain 147, which showed enhanced adherence with fibrinogentreated, virus-infected cell cultures only. This strain was used in all subsequent experiments. To determine whether adherence of strain 147 was statistically significant, the adherence test was repeated with multiple plates (Table 2) . Adherence was significantly enhanced (P < 0.0005) to untreated and fibrinogen-treated influenza A/FM/1/47 virus-infected cell cultures when compared with adherence to control cell cultures. In addition, adherence to fibrinogentreated cell cultures was significantly higher (P < 0.0005) when compared with adherence to untreated, virus-infected cells. The adherence of strain 147 to virus-infected cells increased with increased concentrations of fibrinogen used to treat the cell cultures (Fig. 1) .
The next series of experiments were performed to determine the specificity of fibrinogen-enhanced adherence. In the first experiment, the effect of virus strain used to infect cells was tested. Fibrinogen was dramatically effective in enhancing adherence to MDCK cells infected with the FM1 strain, moderately effective with the Jap 305 strain, and not effective at all with the NWS strain (Fig. 2) . The (Fig. 2) . For example, adherence to untreated MDCK cells infected with virus strain FM1 was significantly increased when compared with adherence to untreated control cultures; however, this effect was only seen when the dilution of virus used to infect cells was .1:90.
Species specificity was examined by using fibrinogen obtained from three different sources-human, canine, and porcine-to treat monolayers (Table 3) . Enhanced bacterial adherence was seen only with virus-infected cell cultures treated with human fibrinogen.
The commercial preparations of human and canine fibrinogen which were used in our studies were contaminated with fibronectin (cold insoluble protein of plasma) as determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (14) in 5% gel (data not shown). Because fibronectin is known to mediate certain types of cell adhesion (9), we tested the possibility that fibronectin was actually mediating the enhanced adherence phenomenon seen in our study. The results of adherence tests with fibronectin-treated monolayers did not mimic results obtained with fibrinogen-treated monolayers (Table 4 ). In addition, treatment of monolayers with sodium citrate, which was also present in the commercial preparations of fibrinogen, had no effect on adherence.
Results from several experiments gave further support to the idea that fibrinogen was binding directly to virus-infected cells and subsequently enhancing the adherence of streptococci to these cells. Using 125I-labeled human fibrinogen, we were able to show a substantial increase in binding to virus-infected cell cultures (Fig. 3) (Fig. 4) . In addition, fibrinogen-enhanced streptococcal adherence was blocked by reacting fibrinogen-treated, virusinfected cell cultures with monospecific antiserum against fibrinogen ( Table 5 ). The (8, 18, 22) . When virus-infected monolayers were grown in the presence of tunicamycin, fibrinogen-mediated adherence decreased in direct proportion to the concentration of tunicamycin (Fig. 5) . These results suggest that fibrinogen reacts with a virus-induced glycoprotein on the surface membrane of infected cells. DISCUSSION Bacterial adherence is an important initial event in the pathogenesis of some bacterial infections in humans. At least three mechanisms have evolved over the last decade to explain the phenomenon of specific bacterial adherence to cells and tissues. "Native" adhesins on the surface of bacteria recognize and react with the following: (i) native receptors on the surface of host cells (3), (ii) "induced" receptors on host cells as exemplified by the enhanced adherence of bacteria to mammalian cell membranes altered by infection with influenza A virus (5, 20, 21) , and (iii) "acquired" receptors that are present on the surface of host cells, but are not synthesized by the cells (2, 6) . I. the present study, we report that human fibrinogen, an acquired receptor, acts as a bridge to bind group A Streptococcus to mammalian cells in vitro. The binding is unique because the mammalian cells must first be infected with influenza A virus for the cross-linking to occur.
A series of experiments was done to demonstrate specificity of the fibrinogen-mediated binding. The adherence of 3H-labeled streptococci increased when progressively increasing concentrations of fibrinogen were used to treat virus-infected monolayers and showed saturation kinetics (Fig. 1) . Fibrinogen bound directly to virus-infected cell membranes, as shown by indirect immunofluorescence (Fig. 4) and direct radioassay (Fig. 3) . Fibrinogen-mediated streptococcal binding was inhibited by monospecific antifibrinogen antiserum ( ed cells in the presence of tunicamycin. Tunicamycin has been shown to inhibit the formation of N-acetylglucosamine-pyrophosphoryldolichol in cell extracts of various tissues (7, 24) . This lipid intermediate is essential for the formation of lipid-linked oligosaccharides which participate in glycosylation of those proteins having a mannose-N-acetylglucosamine core oligosaccharide attached to asparagine on the protein (8, 18) . These results strongly suggest that either hemag- (18, 21) . Strain 147 showed significant adherence to virus-infected cell cultures that had not been pretreated with fibrinogen (Tables 2 and 4 ), but this enhanced adherence was not a consistent feature of the bacterium (Table 3 ). The reason for this observation is unknown; however, it appears that enhanced adherence required optimum conditions for virus infection of the monolayers, e.g., virus dose (Fig. 2) . Other factors such as stage of infection, time, temperature, and pH may be important as has been shown to be the case with enhanced adherence of S. aureus to virus-infected cells (5) . The Table 2 ). The interaction of group A Streptococcus with human fibrinogen is not surprising; the phenomenon was first reported by Tillett and Garner (23) in 1934. The binding site for fibrinogen was later identified by Kantor (11) as streptococcal M protein, and Hryniewicz et al. (10) have proposed that the interaction between fibrinogen and purified M protein be classified as a paracoagulation reaction of a type induced by anionic polymers. Recent studies by Kronvall et al. (12, 13) indicate that the streptococcal binding site for fibrinogen is distinct from the binding sites for immunoglobulin G, immunoglobulin A, aggregated ,2-microglobulin, haptoglobin, and albumin.
We have shown that human fibrinogen is an acquired receptor of influenza A virus-infected cells that can mediate the binding of certain strains of group A Streptococcus. These streptococci are among the bacterial pathogens of humans that are known to be synergistic with influenza A virus, clinically and experimentally. In humans, 17 to 20% of the total body fibrinogen is located extravascularly (1). During influenza virus infection of air passages, hyperemia and edema are regularly observed in the area of virus infection (17) . With this fluid accumulation, presumably fibrinogen concentration would also increase and be available to crosslink virus-infected cells and pyogenic cocci which, in turn, could lead to bacterial colonization and superinfection. Additional studies are required to determine whether this mechanism functions in vivo.
